Baystate Wealth Management’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q4 | $179K | Buy |
322
+14
| +5% | +$7.77K | 0.01% | 211 |
|
2023
Q3 | $135K | Hold |
308
| – | – | 0.01% | 227 |
|
2023
Q2 | $155K | Buy |
308
+58
| +23% | +$29.1K | 0.01% | 210 |
|
2023
Q1 | $125K | Buy |
250
+9
| +4% | +$4.5K | 0.01% | 224 |
|
2022
Q4 | $98K | Buy |
241
+11
| +5% | +$4.47K | 0.01% | 254 |
|
2022
Q3 | $75K | Buy |
230
+14
| +6% | +$4.57K | 0.01% | 263 |
|
2022
Q2 | $76K | Sell |
216
-2
| -0.9% | -$704 | 0.01% | 269 |
|
2022
Q1 | $119K | Buy |
218
+67
| +44% | +$36.6K | 0.01% | 224 |
|
2021
Q4 | $99K | Buy |
151
+15
| +11% | +$9.83K | 0.01% | 244 |
|
2021
Q3 | $85K | Hold |
136
| – | – | 0.01% | 237 |
|
2021
Q2 | $86K | Hold |
136
| – | – | 0.01% | 223 |
|
2021
Q1 | $67K | Buy |
136
+17
| +14% | +$8.38K | 0.01% | 232 |
|
2020
Q4 | $59K | Buy |
119
+2
| +2% | +$992 | 0.01% | 235 |
|
2020
Q3 | $46K | Sell |
117
-72
| -38% | -$28.3K | 0.01% | 229 |
|
2020
Q2 | $62K | Buy |
189
+75
| +66% | +$24.6K | 0.01% | 206 |
|
2020
Q1 | $28K | Sell |
114
-180
| -61% | -$44.2K | ﹤0.01% | 246 |
|
2019
Q4 | $77K | Hold |
294
| – | – | 0.01% | 189 |
|
2019
Q3 | $80K | Hold |
294
| – | – | 0.01% | 171 |
|
2019
Q2 | $82K | Hold |
294
| – | – | 0.01% | 170 |
|
2019
Q1 | $66K | Hold |
294
| – | – | 0.01% | 183 |
|
2018
Q4 | $59K | Hold |
294
| – | – | 0.01% | 182 |
|
2018
Q3 | $64K | Buy |
294
+42
| +17% | +$9.14K | 0.01% | 170 |
|
2018
Q2 | $59K | Hold |
252
| – | – | 0.01% | 172 |
|
2018
Q1 | $50K | Hold |
252
| – | – | 0.01% | 187 |
|
2017
Q4 | $46K | Hold |
252
| – | – | 0.01% | 205 |
|
2017
Q3 | $40K | Hold |
252
| – | – | 0.01% | 207 |
|
2017
Q2 | $42K | Buy |
252
+180
| +250% | +$30K | 0.01% | 196 |
|
2017
Q1 | $11K | Hold |
72
| – | – | ﹤0.01% | 329 |
|
2016
Q4 | $8K | Buy |
+72
| New | +$8K | ﹤0.01% | 323 |
|
2013
Q3 | – | Sell |
-72
| Closed | -$3K | – | 111 |
|
2013
Q2 | $3K | Buy |
+72
| New | +$3K | ﹤0.01% | 251 |
|